ID20968A - Kroman tersubstitusi sulfonamida, proses pembuatannya, penggunaannya sebagai obat, dan sediaan farmasi yang mengandung bahan tersebut - Google Patents
Kroman tersubstitusi sulfonamida, proses pembuatannya, penggunaannya sebagai obat, dan sediaan farmasi yang mengandung bahan tersebutInfo
- Publication number
- ID20968A ID20968A IDP981280A ID981280A ID20968A ID 20968 A ID20968 A ID 20968A ID P981280 A IDP981280 A ID P981280A ID 981280 A ID981280 A ID 981280A ID 20968 A ID20968 A ID 20968A
- Authority
- ID
- Indonesia
- Prior art keywords
- christants
- medicine
- contain
- making
- materials
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
- C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19742509A DE19742509A1 (de) | 1997-09-26 | 1997-09-26 | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID20968A true ID20968A (id) | 1999-04-01 |
Family
ID=7843709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDP981280A ID20968A (id) | 1997-09-26 | 1998-09-24 | Kroman tersubstitusi sulfonamida, proses pembuatannya, penggunaannya sebagai obat, dan sediaan farmasi yang mengandung bahan tersebut |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US5955607A (hu) |
| EP (1) | EP0905131B1 (hu) |
| JP (1) | JP4279920B2 (hu) |
| KR (1) | KR19990030119A (hu) |
| CN (1) | CN1212964A (hu) |
| AR (1) | AR013518A1 (hu) |
| AT (1) | ATE215942T1 (hu) |
| AU (1) | AU741810B2 (hu) |
| BR (1) | BR9803974A (hu) |
| CA (1) | CA2249074A1 (hu) |
| CZ (1) | CZ293681B6 (hu) |
| DE (2) | DE19742509A1 (hu) |
| DK (1) | DK0905131T3 (hu) |
| ES (1) | ES2175582T3 (hu) |
| HR (1) | HRP980527B1 (hu) |
| HU (1) | HU224029B1 (hu) |
| ID (1) | ID20968A (hu) |
| IL (1) | IL126279A (hu) |
| MY (1) | MY119575A (hu) |
| NO (1) | NO319563B1 (hu) |
| NZ (1) | NZ332029A (hu) |
| PL (1) | PL328855A1 (hu) |
| PT (1) | PT905131E (hu) |
| RU (1) | RU2208611C2 (hu) |
| SI (1) | SI0905131T1 (hu) |
| SK (1) | SK282955B6 (hu) |
| TR (1) | TR199801902A3 (hu) |
| TW (1) | TW517053B (hu) |
| ZA (1) | ZA988790B (hu) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19742508A1 (de) * | 1997-09-26 | 1999-04-01 | Hoechst Marion Roussel De Gmbh | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen |
| DE19748469A1 (de) * | 1997-11-03 | 1999-05-06 | Hoechst Marion Roussel De Gmbh | Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
| IL141341A0 (en) * | 1998-09-04 | 2002-03-10 | Procter & Gamble | Substituted dihydrobenzopyrans useful as antiarrhythmic agents |
| DE19858253A1 (de) * | 1998-12-17 | 2000-06-21 | Aventis Pharma Gmbh | Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden |
| US8225458B1 (en) | 2001-07-13 | 2012-07-24 | Hoffberg Steven M | Intelligent door restraint |
| US7368582B2 (en) | 2003-10-17 | 2008-05-06 | Solvay Pharmaceuticals Gmbh | Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3737195A1 (de) * | 1987-11-03 | 1989-05-18 | Bayer Ag | Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| US5104890A (en) * | 1989-03-28 | 1992-04-14 | Fujisawa Pharmaceutical Company, Ltd. | Benzopyran derivatives and processes for preparation thereof |
| US5428031A (en) * | 1991-12-03 | 1995-06-27 | Merck & Co., Inc. | Methods of treating cardiac arrhythmia |
| TR199700369A2 (xx) * | 1996-05-15 | 1997-12-21 | Hoechst Ag | S�lfonamid ile s�bstit�e edilmi� kroman'lar, bunlar�n �retilmesine mahsus usul, ila� veya diyagnostik olarak kullan�lmalar� ve bunlar� i�eren ila�. |
| DE19706675A1 (de) * | 1997-02-20 | 1998-08-27 | Hoechst Ag | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1997
- 1997-09-26 DE DE19742509A patent/DE19742509A1/de not_active Withdrawn
-
1998
- 1998-09-17 IL IL12627998A patent/IL126279A/en not_active IP Right Cessation
- 1998-09-19 AT AT98117809T patent/ATE215942T1/de not_active IP Right Cessation
- 1998-09-19 ES ES98117809T patent/ES2175582T3/es not_active Expired - Lifetime
- 1998-09-19 SI SI9830203T patent/SI0905131T1/xx unknown
- 1998-09-19 DE DE59803704T patent/DE59803704D1/de not_active Expired - Lifetime
- 1998-09-19 PT PT98117809T patent/PT905131E/pt unknown
- 1998-09-19 DK DK98117809T patent/DK0905131T3/da active
- 1998-09-19 EP EP98117809A patent/EP0905131B1/de not_active Expired - Lifetime
- 1998-09-22 CN CN98119538A patent/CN1212964A/zh active Pending
- 1998-09-24 RU RU98117613/04A patent/RU2208611C2/ru not_active IP Right Cessation
- 1998-09-24 NZ NZ332029A patent/NZ332029A/xx unknown
- 1998-09-24 TR TR1998/01902A patent/TR199801902A3/tr unknown
- 1998-09-24 BR BR9803974-1A patent/BR9803974A/pt not_active Application Discontinuation
- 1998-09-24 ID IDP981280A patent/ID20968A/id unknown
- 1998-09-24 SK SK1319-98A patent/SK282955B6/sk unknown
- 1998-09-24 MY MYPI98004390A patent/MY119575A/en unknown
- 1998-09-24 CZ CZ19983069A patent/CZ293681B6/cs not_active IP Right Cessation
- 1998-09-24 AR ARP980104776A patent/AR013518A1/es unknown
- 1998-09-25 NO NO19984475A patent/NO319563B1/no unknown
- 1998-09-25 ZA ZA988790A patent/ZA988790B/xx unknown
- 1998-09-25 AU AU87083/98A patent/AU741810B2/en not_active Ceased
- 1998-09-25 HU HU9802156A patent/HU224029B1/hu not_active IP Right Cessation
- 1998-09-25 HR HR980527A patent/HRP980527B1/xx not_active IP Right Cessation
- 1998-09-25 PL PL98328855A patent/PL328855A1/xx unknown
- 1998-09-25 KR KR1019980039835A patent/KR19990030119A/ko active IP Right Grant
- 1998-09-25 US US09/160,304 patent/US5955607A/en not_active Expired - Lifetime
- 1998-09-25 CA CA002249074A patent/CA2249074A1/en not_active Abandoned
- 1998-09-25 JP JP27216798A patent/JP4279920B2/ja not_active Expired - Lifetime
- 1998-10-22 TW TW087115866A patent/TW517053B/zh active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID26399A (id) | Turunan 1-(1-tersubstitusi-4-piperidinil) metil -4-piperidin, proses pembuatannya, komposisi farmasi yang mengandung senyawa tersebut, dan intermedietnya | |
| ID26207A (id) | ESTRATRIENA TERSUBSTITUSI 11β-HALOGEN-7 αTERSUBSTITUTASI, PROSES UNTUK MEMPRODUKSI SEDIAAN FARMASI YANG MENGANDUNG ESTRATRIENA 11β-HALOGEN-7 αINI DAN JUGA PENGGUNAANNYA UNTUK PRODUKSI ZAT-ZAT FARMASI | |
| ID22821A (id) | Turunan sulfonamida, proses pembuatannya dan penggunaannya sebagai obat | |
| ID24714A (id) | Turunan tiazolidindion tersubstitusi, proses pembuatannya dan penggunaan bahan farmasinya | |
| ID22528A (id) | Komposisi farmasi fenofibrat yang memiliki biovabilitas tinggi dan metoda pembuatannya | |
| ID26420A (id) | Indolinon-indolinon tersubstitusi baru, pembuatannya dan penggunaannya sebagai komposisi-komposisi farmasi | |
| EE9700031A (et) | Pürido-liitunud tienüül- ja furanüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid | |
| ID25528A (id) | Karboksamidotiazol tersubstitusi, pembuatannya dan komposisi farmasi yang mengandungnya | |
| ID18613A (id) | Oksadiazol baru, proses pembuatannya serta penggunaannya sebagai komposisi farmasi | |
| ID26589A (id) | 4-haloalkil -3-heterosiklilpiridina dan 4- haloalkil-5-heterosiklilpirimidina proses untuk pembuatannya komposisi yang terdiri darinya dan pemakaiannya sebagai pestisida | |
| ID19574A (id) | Lingkar-lingkar aneka beranggota-5 yang mempunyai substitusi bifenilsulfonil, proses pembuatannya penggunaannya sebagai obat atau diagnosa dan obat yang terdiri dari zat-zat itu | |
| NO982302D0 (no) | Farmas÷ytisk sammensetning | |
| ID25543A (id) | Alpha-aril-n-alkinitron dan komposisi farmasi yang mengandungnya | |
| EP0740937A3 (fr) | Utilisation de rétinoides pour la fabrication d'une composition cosmétique ou pharmaceutique | |
| ID25516A (id) | Senyawa-senyawa yang mengandung cincin-cincin beranggotakan enam, proses pembuatannya, dan penggunaannya sebagai obat | |
| ID27558A (id) | Amida-amida aromatik baru, metode pembuatannya dan penggunaannya sebagai obat | |
| ID20137A (id) | Turunan propanolamina, proses pembuatannya, sediaan farmasi yang mengandung senyawa ini, dan penggunannya | |
| ID17810A (id) | Turunan-turunan 2,4-tiazolidindion tersubstitusi baru, proses untuk pembuatannya dan komposisi farmasi yang mengandungnya | |
| ID20604A (id) | Polisakarida sintetis proses untuk pembuatan dan komposisi farmasi yang dikandungnya | |
| ID22911A (id) | Turunan-turunan triazol baru, proses pembuatan dan komposisi-komposisi farmasi yang mengandungnya | |
| ID20967A (id) | Kroman tersubstitusi sulfonamida, proses pembuatannya, penggunaannya sebagai obat, dan sediaan farmasi yang mengandung bahan tersebut | |
| EE200000226A (et) | 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon | |
| ID24173A (id) | 1,2,3,4,5,6 heksahidro-2-6-metano-3-benzazosin-10-ol, proses pembuatan dan penggunannya untuk obat-obatan | |
| ID18817A (id) | 3-amidokromanilsulfonil (tio) urea, proses untuk pembuatan, penggunaan, dan sediaan-sediaan farmasi yang mengandungnya | |
| ID16989A (id) | 2-naftoilguanidin tersubstitusi, proses untuk pembuatannya, pemakaiannya sebagai obat atau diagnostik, dan obat yang mengandungnya |